Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-03-18 Sale | 2022-03-22 7:26 pm | Design Therapeutics Inc. | DSGN | Xu Stella Director | 590,880 | $19.07 | $11,266,197 | 4,139,950 (Indirect) | View |
| 2021-03-30 Purchase | 2021-04-01 6:19 pm | Design Therapeutics Inc. | DSGN | Xu Stella Director 10% Owner | 10,000 | $20 | $200,000 | 4,730,830 (Indirect) | View |
| 2019-05-13 Purchase | 2019-05-13 7:32 pm | NextCure Inc. | NXTC | Xu Stella Director | 125,000 | $15 | $1,875,000 | 1,103,570 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-06-15 Option Award | 2022-06-16 5:17 pm | N/A 2032-06-14 | Design Therapeutics Inc. | DSGN | Xu Stella Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-07-01(A) Option Award | 2021-09-20 8:10 pm | N/A 2031-06-30 | Tempest Therapeutics Inc. | TPST | Xu Stella Director | 6,635 | $0 | 6,635 (Direct) | View |
| 2021-07-01 Option Award | 2021-07-06 6:05 pm | N/A 2031-06-30 | Tempest Therapeutics Inc. | TPST | Xu Stella Director | 6,635 | $0 | 6,635 (Direct) | View |
| 2021-06-25 Option Award | 2021-06-29 9:56 pm | N/A N/A | Millendo Therapeutics Inc. | TPST | Xu Stella Director | 579,710 | $0 | 579,710 (Indirect) | View |
| 2021-06-24 Option Award | 2021-06-28 6:16 pm | N/A 2031-06-23 | NextCure Inc. | NXTC | Xu Stella Director | 14,250 | $0 | 14,250 (Direct) | View |
| 2021-03-30 Conversion | 2021-04-01 6:19 pm | N/A N/A | Design Therapeutics Inc. | DSGN | Xu Stella Director 10% Owner | 12,415,784 | $0 | 4,730,830 (Indirect) | View |
| 2021-03-25 Option Award | 2021-03-29 6:31 pm | N/A 2031-03-24 | Design Therapeutics Inc. | DSGN | Xu Stella Director 10% Owner | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-03-25 Ownership | 2021-03-25 9:15 pm | N/A N/A | Design Therapeutics Inc. | DSGN | Xu Stella Quan Venture Fund II L.P. Director 10% Owner | 0 | $0 | 4,720,830 (Indirect) | View |
| 2020-06-11 Option Award | 2020-06-15 5:47 pm | N/A 2030-06-10 | NextCure Inc. | NXTC | Xu Stella Director | 14,250 | $0 | 14,250 (Direct) | View |
| 2019-06-13 Option Award | 2019-06-17 8:20 pm | N/A 2029-06-12 | NextCure Inc. | NXTC | Xu Stella Director | 22,000 | $0 | 22,000 (Direct) | View |
| 2019-05-13 Conversion | 2019-05-13 7:32 pm | N/A N/A | NextCure Inc. | NXTC | Xu Stella Director | 8,840,206 | $0 | 1,103,570 (Indirect) | View |
| 2019-05-08 Ownership | 2019-05-08 8:04 pm | N/A N/A | NextCure Inc. | NXTC | Xu Stella Quan Venture Fund II L.P. Director 10% Owner | 0 | $0 | 978,570 (Indirect) | View |
| 2018-06-22 Disposition | 2018-06-22 7:34 pm | N/A 2028-03-25 | ARMO BioSciences Inc. | ARMO | Xu Stella Director | 18,000 | $10.03 | 0 (Direct) | View |
| 2018-06-22 Equity Swap | 2018-06-22 7:34 pm | N/A N/A | ARMO BioSciences Inc. | ARMO | Xu Stella Director | 404,900 | $50 | 0 (Indirect) | View |
| 2018-03-26 Option Award | 2018-03-28 4:56 pm | N/A 2028-03-25 | ARMO BioSciences Inc. | ARMO | Xu Stella Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2018-01-30 Conversion | 2018-01-30 5:09 pm | N/A N/A | ARMO BioSciences Inc. | ARMO | Xu Stella Director | 404,900 | $0 | 404,900 (Indirect) | View |
| 2018-01-25 Ownership | 2018-01-25 6:06 pm | N/A N/A | ARMO BioSciences Inc. | ARMO | Xu Stella Director | 0 | $0 | 404,900 (Indirect) | View |